miR-940 may suppress tumor cell invasion and migration via regulation of the migration and invasion enhancer 1 protein in prostate cancer (36), the inhibition of phosphorylation of myosin II in breast cancer (37), and the regulation of CXC chemokine receptor 2 in hepatocellular carcinoma (38). Here, CXCR2 is linked to neoplasm.